Diabetes- is patient knowledge the key to self-management

Authors

  • Claire Fitzsimmons
  • Brid Hollywood

Keywords:

medicine

Abstract

Type 2 diabetes is a chronic metabolic disorder and community-based management
poses many challenges to both healthcare professionals and patients. This article
explores the attitudes of two different diabetic patients towards their condition by
means of informal interviews. The relationship between patient knowledge and
compliance with treatment regimes is also investigated through the two case studies.
Current strategies for managing Type 2 diabetes in the primary-care setting are also
reviewed.

References

1. Verma L, Prakash G, Tewari HK. Diabetic retinopathy: time for action. No
complacency please! Bull World Health Organ. 2002;80:419
2. O’Sullivan T. Type 2 diabetes management. Forum distance learning programme,
Module 83: July 2004
3. Guidelines for good practice in the diagnosis and treatment of non-insulin dependent
diabetes mellitus. Report of a joint working party of the British Diabetic Association, the
Research Unit of the Royal College of Physicians, and the Royal College of General
Practitioners. J R Coll Physicians Lond. 1993:27:259-66
4. Colwell JA. Controlling type 2 diabetes: are the benefits worth the costs? JAMA
1997;278:1700
5. Management of Non-Insulin Dependent Diabetes Mellitus (NIDDM). National
Medicines Information Centre Bulletins, Vol 3 No 6 1997
6. McDonnell B. To empower or to disempower? – that is the question. Diabeteswise,
Volume 2 Issue 1 Spring 2005
7. Smith SM, O'Leary M, Bury G. Shannon, W, Tynan, A, Staines, A. and Thompson,
C. A qualitative investigation of the views and health beliefs of patients with Type 2 diabetes
following the introduction of a diabetes shared care service. Diabet Med 2003; 20:853-857
8. Williams G. Management of non-insulin-dependent diabetes mellitus. Lancet
1994;343:95-100
9. O’Connor R. Practice prevention of diabetes complications. Forum distance learning
programme, March 2005.
10. Boyle-Thomas P. Diet and diabetic nephropathy. Diabeteswise, Volume 2 Issue 1
Spring 2005
11. Brooker L, O’Brien C, Acheson R. Modifiable risk factors affecting progression of
diabetic retinopathy. Diabeteswise, Volume 1 Issue 4 Winter 2004
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose-control
with sulphonylureas or insulin compared with conventional treatment and risk of
complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
13. Klein S, Sheard NF, Pi-Sunyer X et al. Weight management through lifestyle
modification for the prevention and management of type 2 diabetes: rationale and strategies.
Diabetes Care 2004;27:2067-2073
14. Krentz AJ, Bailey CJ, Melander A. Thiazolidinediones for type 2 diabetes. New
agents reduce insulin resistance but need long term clinical trials. BMJ. 2000;321:252-3.
15. Colhoun HM, Betteridge J, Durrington PN et al. Primary prevention of cardiovascular
disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study
(CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96
16. Freeman DJ, Norrie J, Sattar N et al. Pravastatin and the development of diabetes
mellitus: evidence for a protective treatment effect in the West of Scotland Coronary
Prevention Study (WOSCOPS). Circulation 2001;103:357-62
17. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with
macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective
observational study. BMJ 2000;321:412-9

Downloads

Published

2006-01-01

How to Cite

Fitzsimmons , C. . ., & Hollywood, B. (2006). Diabetes- is patient knowledge the key to self-management. Trinity Student Medical Journal , 7(1). Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1939

Similar Articles

<< < 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.